Transcript Document

Multifunctional bioresorbable biocompatible coatings
with biofilm inhibition and optimal implant fixation
IP-SME MEDDELCOAT 2006-2010
Background
Most common reasons for revision surgery of implants are loosening (65%), dislocation (9%) and infection (7%). The revision rate of
orthopaedic implants is between 10-20% after 15-20 years. For dental implants it is 15% over a 5-year period. Biofilm formation is the
major pathogenic factor.
Objectives
The project aims at gaining the scientific and processing knowledge to develop the next generation
of multifunctional, bioactive, biocompatible coatings for orthopaedic and dental implants with
biofilm inhibition and optimal implant fixation.
The envisaged radical innovations and major breakthroughs are:
Shoulder
prostheses
Dental implant
• New substrates and coatings with enhanced biocompatibility
• Radically new or improvement of existing coating techniques
for processing
bioresorbable and biocompatible coatings with a graded interface and tailored porosity
• In-depth understanding of implant substrate/coating/bone interface structure, design and
engineering of optimal implant fixation
Acetabular cups
Hip implant
• Knowledge on biofilm formation and inhibition
• Formulation and evaluation of biofilm inhibitors incorporated into the coating
Porous bioactive coating processing techniques
Amongst the techniques to realise the porous bioactive coating are:
• Vacuum plasma spraying
• Sol-gel processing
• Electrophoretic deposition
• Selective laser sintering
• Dip coating
• Plasma Enhanced Chemical Vapour Deposition (PE-CVD)
• Laser assisted microwave processing
Vacuum plasma spraying
CO2-laser
Laser
Thermal Insulation
Conventional
heating system
Microwave source
2.45 GHz
Laser supported
MW plasma
Substrate
Electrophoretic deposition and dip-coating
PE-CVD
Laser assisted microwave processing
Materials
Ti6Al4V and CoCrMo alloys are most commonly used for orthopaedic applications, whereas pure Ti is used for dental implants. In
the project, new nanostructered titanium-based alloy implant substrates will be developed and evaluated. To promote
osteointegration the substrate is coated with a bioactive top layer based on calcium phosphate, bioactive glass or titania.
Hydroxyapatite infiltrated vacuum plasma sprayed porous Ti coatings are used as reference material.
Biofilm inhibiting coating
Staphylococcal biofilms
Drug delivery platform
Model micro-organism systems will be used to
investigate and select the most suitable antimicrobial substances active during a reasonable
and optimal period to reduce infection and biofilm
formation to a minimum. A suitable drug delivery
platform will be designed and the controlled
release of the selected anti-infectives from the new
substrate-coating biomaterial systems will be
studied in vitro.
Expectations
Reducing the need for implant revision due to loosening and infection by designing and engineering an implant surface to optimise
fixation, promoting osteointegration by applying a bioactive coating and incorporating a biofilm formation inhibiting function.
LEMI
www.meddelcoat.eu